Definitive Healthcare Corp. (DH) stock: key figures, P/E, revenue and dividend
Information Technology · United States · ISIN US24477E1038
Definitive Healthcare Corp. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 241.52 m USD |
| Gross profit | 183.28 m USD |
| Operating income | -224.27 m USD |
| EBIT | -197.97 m USD |
| Net income | -138.93 m USD |
| Diluted EPS – continuing operations | -1.30 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Definitive Healthcare Corp.
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, marketing and advertising agencies.Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
More stocks
- Pyrum Innovations (PYR.DE)
- ReposiTrak, Inc. (TRAK)
- Scottie Resources Corp (SCOT.V)
- Jean Co Ltd (2442.TW)
- Epoch Chemtronics Corp. (3633.TWO)
- Kt Skylife (053210.KS)
- INSAN Inc. (277410.KQ)
- Yuhwa Securities Co Ltd (003465.KS)
- Kwan's International Co., Ltd. (6101.TWO)
- Win Win Precision Technology Co., Ltd. (4949.TW)
- TPG Mortgage Investment Trust, Inc. (MITT)
- Cannara Biotech Inc. (LOVE.TO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.